LISTEN TO THE Organizing Committee Members

Istvan J Enyedy

Theseus Pharmaceuticals, USA

In the past 21 years Istvan J Enyedy has been involved in new target evaluation, hit finding, and hit-to-lead optimization projects for several types of target classes using both ligand and structure-based methods. He is coauthor on more than 50 publications and 14 patents/applications. He received his PhD in 1998 at Catholic University of America, Washington DC, and did postdoctoral training in Dr. Shaomeng Wang’s group at Georgetown University Medical Center, Washington DC. Between 2001 and 2021 he worked at Bayer Pharmaceuticals, West Haven CT, Novartis Institutes for Biomedical Research, Biogen, and Black Diamond Therapeutics in Cambridge MA. Since September 2021 he has been at Theseus Pharmaceuticals, in Cambridge MA.

Alain L. Fymat

Weil Institute of Critical Care Medicine, USA

Prof. Dr. Alain L. Fymat is a medical-physical scientist and an educator. He is the current President/ CEO and Institute Professor at the International Institute of Medicine & Science with a previous appointment as Executive Vice President/Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine, California, U.S.A. He was formerly Professor of Radiology, Radiological Sciences, Radiation Oncology, Critical Care Medicine, and Physics at several U.S. and European Universities. Earlier, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs (Office of Research Oversight). At the Loma Linda Veterans Affairs Medical Center, he was Scientific Director of Radiology, Director of the Magnetic Resonance Imaging Center and, for a time, Acting Chair of Radiology. Previously, he was Director of the Division of Biomedical and Biobehavioral Research at the University of California at Los Angeles/Drew University of Medicine and Science.

Ana Brotons-Canto

Nucaps Nanotechnology, Spain

Ana Brotons-Canto is a R&D Manager at Nucaps Nanotechnology, Spain. She has done her PhD in Pharmacy and Master’s Degree in Drug Research, Development and Innovation. She has 9 years’ experience in nanotechnological developments.

Andrea Bizzi

Chiesi Germany GMBH – Hamburg, Germany

Currently Andrea Bizzi works as Managing Director with an outstanding record in delivering revenue growth and governance across EMEA and Asia-Pac through in-depth understanding of the pharmaceutical sector. Adept at developing sales-winning marketing strategies, analysing existing and potential markets and sound knowledge of growth requirements to exceed targets and deliver brand and product objectives. Leads marketing, market access/pricing initiatives and strategies by focusing on building long-lasting relationships that are based on trust and geared for longevity. A dynamic leader with a flair for understanding customer needs and a talent for leadership, who now seeks a new challenge and utilise branding and marketing expertise to deliver financial success.

John Reeves

conversationHEALTH, Canada

Dr. Reeves is a global expert in the application of conversational AI to healthcare. He has over 25 years of experience as an engineer, primary care physician, and entrepreneur. He’s the CEO and founder of ConversationHealth, which is transforming how life sciences companies engage their patients and healthcare professionals through virtual conversations. Their company has developed a Pharma-specific SaaS platform that powers these human-like experiences across text, voice, and digital human channels, and he’s here to discuss some top tips about what companies should be thinking about when it comes to developing a chatbot solution of their own.

Mahmoud Ameri

Zosano Pharma, USA

Dr. Ameri is one of the co-founders of Zosano Pharma and brings 20 years of drug delivery, preclinical and early ex U.S. clinical development of combination products to the company. He is responsible for research and development. Prior to Zosano, he was at Alza/J&J were he co-invented and developed the Adhesive Dermally Applied Microarray system and holds over 20 patents and patent applications all relating to the Zosano drug delivery technology. Dr. Ameri received his Ph.D. from the School of Pharmacy at the University of Manchester in the United Kingdom.

Chi Udeh-Momoh

Imperial College London, UK

Dr Chi Udeh-Momoh is co-Investigator, scientific coordinator and Programme Manager of several large-scale dementia prevention studies, including a world-class, single-site, epidemiological dementia-prevention programme with >2000 cognitively healthy older adults screened, and data on imaging and fluid biomarkers as well as neurocognitive and lifestyle factors collected at high throughput, alongside her role as Senior Research Associate at Bristol University. In 2018, she began developing the FINGER-AFRICA project (as co-Principal Investigator) that aims to explore the impact of multimodal lifestyle intervention strategies in Sub-Saharan African populations, and related molecular mechanisms contributing to observed effects, with European, US and African collaborators.

Kalliopi Megari

Hellenic Neuropsychological Society, Greece

Dr. Kalliopi Megari is a Clinical Neuropsychologist, Counselling psychologist, Health Care Specialist & General Secretary of the board of directors of Hellenic Neuropsychological Society. Currently doing Postdoctoral degree from Aristotle University of Thessaloniki, Greece. Her educational background from graduation to Postdoc is from Aristotle University. She having more than 20 years of experience in Clinical, Research & Teaching field and having 15+ published articles in reputed journals, 2 books published with 6 Award titles. She having total 60 publications in conference proceedings: 39 International and 21 nationwide Conferences with oral and posters presentations. She is the Editorial member of 33 journals & Reviewer of papers for 15 scientific journals.

Nahlah Elkudssiah Ismail

Council Member, Malaysian Academy of Pharmacy, Malaysia

Prof. Dr. Nahlah Elkudssiah Ismail graduated with a Bachelor Degree in Pharmacy (Hons) from Universiti Kebangsaan Malaysia in the year 2000 with Pharmacy Board of Malaysia registration in 2001. Prof. Dr. Nahlah successfully awarded a PhD degree (Distinction Report) in the field of clinical pharmaceutics at Institute of Pharmaceutical Innovation (IPI) and School of Pharmacy, University of Bradford, Bradford, United Kingdom (UK) in July 2005. With experience gained over two decades of work in the academia, community pharmacies, hospitals, clinics, vaccination centres, research centres, and industries, to date, she has taught more than 75 courses to diploma, degree and postgraduate students in United Kingdom and Malaysia using innovative teacher- and student- centered learning. As the pioneer of clinical pharmaceutics in Malaysia, she is the founder of the first Clinical Pharmaceutics Research Group (CPRG) (2008) in Malaysia and that was later acknowledged as Clinical BioPharmaceutics Research Group (CBRG) under Research Initiative Group (RIG) by Research Management Institute (RMI), Universiti Teknologi MARA (UiTM), Malaysia. The CBRG comprised of Inhalational Delivery Lab (IDL), Biomedical Analysis Lab (BAL) and Honey Research Lab. IDL was the first in Asia comprising all pivotal facilities in analyzing particles deliveries emitted from various medical devices including nasal spray, metered dose inhalers, spacers, dry powder inhalers, and various types of nebulisers, industrial and domestics sprays, as well as environmental air quality assessment ranging from nano to micro sizes of particles. Prof. Dr. Nahlah holds membership in various local and international pharmacy and health based organizations. She has been publishing more than 300 publications including reputable research journal articles, proceedings, chapters in books, books and magazine. She has been invited to deliver lectures, talks (guest of honour/keynote/plenary/distinguished/eminent speaker) and conduct workshops at local and international events as well as a reviewer and editorial board member for local and international journals, and serve organizing committee members in various conferences. dult, geriatric, adolescent and children.

Ahmed G. Hegazi

National Research Center, Egypt

Ahmed Hegazi is currently a Professor of Microbiology and Immunology in the National Research Center, Egypt. Prof. Hegazi received his master’s degree in 1979, and his PhD in 1981. Hegazi’s research work has been focused lately on bee products and their therapeutic effects. Dr. Hegazi awards; First Class Decoration of Excellence, Egypt, 1995, The Senior Scientist Prize of National Research Center, Cairo, Egypt, 1996, The National Scientific Prize In Biological Sciences, Egypt, 1990, The Scientific Prize of The National Research Center, Cairo, Egypt, 1989, The Second Best Research Paper Award, International Congress of Propolis, Bones Aires, Argentina, 2000, Main Speaker Award,10th Academic Conference, PRA and NAS (Nippon Apitherapy Soc.) Japan, 2006, 2 Bronze medals from The International Innovation Fair of the Middle East, Kuwait, 2007 Awarded of Ghazi Wad Allah Salon Prize, 2008. Awarded the Merit Aware of Medical Sciences, The National Research Center, 2016.
Dr. Hegazi contributed Chairman of the National Committee for Microbiological Sciences (NCMS) in Egypt, Academy of Science and Technology, Egypt, from 2018. Hegazi organized and contributed to national and international research projects since 1977 and up till now; he has been the principal investigator on multiple research projects within the National Research Center. He Conducted training courses on Clinical Microbiology, National Research Center in 1979. He has 243 articles in national and international scientific journals. Editor in 48 journals, Referee in the 98 International Journals, Organizer of 156 International Symposium and conferences, 9 books in English language and 13 books in Arabic language. He has patent No. 28335at 11/12/2017. and registers for other 5.

Metin Basaranoglu

Bezmialem Vakif University,Turkey

Professor Metin Basaranoglu, received his Medical Doctor degree from Istanbul University in 1993. Then, İnternal Medicine and Gastroenterology fellowship in Turkey. He completed his postdoctoral studies in St. Louis University School of Medicine/Liver Centre, St. Louis/MO, USA (2006-2007). He performed basic science research under the supervision of Prof. Dr. Brent A. N. Tetri, St. Louis, MO, USA. He developed fatty liver mice models (ALIOS mice) and studied oxidative stress on this model. He published one book chapter (Metabolic Aspects of Chronic Liver Diseases) and one book (NASH/NAFLD) published in NY/USA in 2008 and 2009.

Sinisa Franjic

Independent Researcher, Croatia

Dr. Sinisa Franjic graduated from the Faculty of Law of the University of Split. Thesis entitled “Legal aspects of information systems” was defended Summa Cum Laude and he become LLM of Law. Since 1992., he work as a journalist – freelance contributor to the first Radio Osijek of HRT (Croatian Radio Television), and then something shorter, among other media, he work for HTV – TV center Osijek, weekly “Školske novine (School Newspaper)“ and the monthly “Super Kino Video (Super Cinema Video)”. He is studying a Medical Law and a few other legal disciplines. In Faculty of Electrical Engineering in Osijek he was participated in teaching of the courses “Computer Criminality” and “Legal Regulations in Electrical Engineering and Computer Science” and in the Faculty of Medicine in Osijek he participated in teaching of the courses “Social and Health Legislation” and “Medicine and Health Law”. The successful defense of the doctoral dissertation on the topic from criminal law called “The Criminal Justice and Forensic Aspects of Computer Criminality”, he received a PhD degree from the Faculty of Law of the International University of Brcko District in Brcko, Bosnia and Herzegovina.

Tathagata Dutta

CTO : JODAS EXPOIM Pvt. Ltd, India

Dr. Tathagata Dutta has earned his M.Pharm and PhD in Pharmaceutical Sciences from Dr. Hari Singh Gour University, Sagar and completed his postdoctoral studies from School of Pharmacy & Diamantina Institute for cancer, Immunology and Metabolic Medicine, University of Queensland, Brisbane, Australia and was engaged in development of RNAi therapeutics for effective management of cancer. He has served as Chief Scientific Officer (CSO), Vice President (R&D), Executive Director, Managing Director & CEO of several reputed Multinational Pharmaceutical Companies for more than two decades. He has been conferred with several National and International Awards and Honors. He has published several international papers in reputed international journals, several patents and had authored several book chapters. He is the editorial board member of several international journals on drug discovery & delivery research.  His research interests include novel drug delivery systems, dendrimers, liposomes, polymer bioconjugates, tissue targeted drug delivery systems, nano drug delivery systems, gene therapy, genetic immunization, depot injections, gene delivery, and development of RNAi therapeutics. Presently, he is the Chief Technology Officer (CTO) of JODAS EXPOIM Pvt Ltd.